Skip to main content

Pulmonx Corp 10-Q for FY2026 Q3

Pulmonx Corp (LUNG)

10-Q 2026-11-03 For: 2026-09-30
View Original
Added on November 03, 2026

About this 10-Q

Pulmonx Corp filed this 10-Q on November 3, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

Pulmonx Corp generated revenue of $22.8 million for the three months ended September 30, 2026, up 6.2%, while gross margin rose to 76.2% and net loss narrowed 39.9% to $8.4 million. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$22.84M
up 6.2% from $21.5M a year earlier
Net loss
$8.39M
compared with a net loss of $13.96M a year earlier
Diluted EPS
-$0.19
compared with -$0.34 a year earlier